CAR-T cells Infusion chimeric antigen receptor T cells

DRUG2 trials

Sponsors

The First Affiliated Hospital of Soochow University, Institute of Hematology & Blood Diseases Hospital, China

Conditions

Plasma Cell LeukemiaRelapsed/Refractory Multiple MyelomaRelapsed/Refractory Plasma Cell Leukemia

Early Phase 1

A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia

RecruitingNCT06730256

The First Affiliated Hospital of Soochow UniversityRelapsed/Refractory Multiple Myeloma, Relapsed/Refractory Plasma Cell Leukemia

Start: 2025-07-23End: 2027-12-31Target: 24Updated: 2025-10-01

A Study of CT0596 in Plasma Cell Leukemia

RecruitingNCT06988059

Institute of Hematology & Blood Diseases Hospital, ChinaPlasma Cell Leukemia

Start: 2025-06-25End: 2027-12-31Target: 27Updated: 2025-08-01